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Abstract Background: Patients with upper and lower airway symptoms andwith pronounced sensitivity to chemical
odours, such as perfumes, flower scents and tobacco smoke, have been suggested to have sensory hyperreactivity
(SHR).The symptoms have been difficult to identify with physiologicalmeasurements and the effects of variousmedica-
tions are doubtful.However, these patients have been found to bemore sensitive to inhalation of capsaicin than healthy
people.The aimofthis studywas to establish limit valueswiththe capsaicin inhalationtest inpatientswith SHR.Methods:
Ninety-five consecutive patientswith upper and lower airwayproblems, whowere admitted for allergy testing, under-
went a capsaicin inhalation test with three different concentrations.The number of coughs was registered during each
challenge.Score systemswereused for symptoms andinfluence on sociallife of sensitivity to odours.Inrelationto scored
symptoms, the patients were grouped as SHR or not, and compared with 73 healthy controls. Results: All patients and
controls coughedoncapsaicinin a dose-dependentmanner.Symptomscore ofodour sensitivityinpatientswaspositively
correlatedtotheresponse ofthetest.Outof 95 patients,15 (16%)were scoredto SHR.Patientswith SHR reactedmoreto
the capsaicin inhalation test than the other patients and the healthy controls.The limit values for a positive capsaicin in-
halationtest for the SHRwere determinedtobe10,35 and 55 coughs at 0.4, 2.0 and10 mMcapsaicin, respectively. Conclu-
sion:The capsaicin inhalationtest well reflects the degree of airway sensitivity to chemicals and towhatextentthe social
life is influenced. The cut-off values of the test can distinguish patients with pronounced sensitivity to odours.r 2002
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In daily clinical work at our Allergy Centre, we see pa-
tients with symptoms that do not ¢t the common diag-
noses.One group of such patients with upper and lower
airway complaints has pronounced sensitivity to various
odours such as perfumes, cleaning agents, £ower scents,
car exhaust fumes and tobacco smoke.Thesepatients of-
ten have di⁄culty describing their symptoms, the most
common being ‘heavy breathing’, ‘di⁄cult in getting
air’, ‘pressure across the chest’ and ‘blocked nose’.
When lower airway symptoms predominate, the term
‘asthma-like’ has been used, but a main feature among
those patients is the absence of bronchial obstruction
(1). The symptoms have been di⁄cult to identify with
physiological measurements and the e¡ects of variousReceived 25 February 2002, accepted in revised form 28 February
2002.
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500 431658; E-mail: mats.bende@vgregion.semedications are small or doubtful. The suggested me-
chanism behind these symptoms is a sensory hyperreac-
tivity (SHR) (1). SHRhas a strongresemblance tomultiple
chemical sensitivity (MCS), the term used in American
literature,which features symptoms fromvarious organs
including the airways and is caused by exposure to che-
mical substances (2^5).There are no objective methods
to demonstrateMCS, considered tobe a psychogenicdis-
order (6).
In previous provocation tests, we found that patients
with odour sensitivity complained at provocation with
perfume, evenwhen they were unable to smell it, which
contraindicates a purely olfactory stimulation (7,8).
Patients with odour sensitivity reactmore strongly with
cough than do healthy individuals and asthmatics to pro-
vocation with capasaicin inhalation (1). The capsaicin in-
halation is an objective test, as has been demonstrated
in a controlled study (9). The induced cough can be
blockedby local anaesthetics (9), which supports the hy-
pothesis that chemical stimulation of sensory nerve end-
ings, probably the C-¢bres of the trigeminal nerve (10)
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saicin and other vanilloids, butother substancesmay also
activate it (10,11). Stimulation of this receptor could serve
to explain the problems of patients with odour sensitiv-
ity. Sensitivity to capsaicin varies among both healthy
and sick individuals and is directly related to the degree
of odour sensitivity (12). The objectives of the present
study were to establish limit values for the capsaicin in-
halation test.
MATERIALANDMETHODS
Patients
All adult patients presenting with airway problems who
were referred to the Allergy Centre in Sk˛vde during a
period of1year were included in the study. Exclusion cri-
teria were pregnancy and communication di⁄culties.
The latter included both long travelling distance (more
than 1h travelling time) and communication problems
due to language and/or mental state. A total of 143 pa-
tients were presented at the Centre during the above
period.Of these,14 patients were excluded due to com-
munication di⁄culties. By oversight, 3 patients were
never asked whether they wanted to take part in the
study and were consequently excluded. Therefore, 126
patientsF58 men and 68 womenFwere asked
whether they were willing to participate in the study.
Of these, 27 patients declined, representing a non-re-
sponse of 21%. Consequently, 99 patients were studied,
44 men and 51 women between the ages of 18 and 73,TABLE 1. Presentation of 95 patientswithupper and lowerresp
Women (
Sensitivity to odours (mean score,95% CI) 1.9 [1.49;
Social score (mean,95% CI) 0.7 [0.51
Allergy (%) 27 (53
Symptoms fromupper 4 (8%
airwaysbycold air (%)
Symptoms fromlower 13 (25
airwaysbycold air (%)
Rhinitiswith allergy 25 (49
Rhinitiswithout allergy 13 (25
Asthmawith inhalation 10 (20
corticosteroids
Asthmawithout inhalation 6 (12%
corticosteroids
Asthmawith allergy 10 (20
Asthmawithout allergy 6 (12%
Smokers 7 (14%
Previous smokers 7 (14%
Cough 22 (43
Smokers andprevious 3 (6%
smokerswith coughwith an average age of 34 and 36, respectively.They pre-
sented various airway symptoms, schematised inTable1.
All patients were examined with anamneses, an al-
lergyquestionnaire, a skin prick test (sometimes in com-
bination with analysis of speci¢c IgE in serum) and a
clinical status. Spirometry and methacholine tests were
performed in suspected asthma. An evaluation was
made of patients’ sensitivity to smelling chemical sub-
stances, such as perfumes, cleaning agents, £ower
scents, tobacco smoke and car exhaust fumes, on a scale
of 0^3 (0=no sensitivity; 1=mild sensitivity; 2=moder-
ate sensitivity; and 3= strong sensitivity) for the upper
respiratory airways including the larynx and the lower
airways. The maximum score was 6 and the minimum
was 0 point. In addition, an evaluationwasmade in order
to determine social e¡ects of sensitivity to odorous sub-
stances.The patients were thus classi¢ed into ¢ve cate-
gories: 0=no social e¡ects; 1=occasional problems at
home, at leisure and at theworkplace; 2=dailyproblems
at work; 3= intermittent sick leave; and 4= long-term
sick leave or disability pension. The results of allergy
tests, the diagnosis and thepatients’ sensitivity to odours
are presented inTable 1.One patient had simple chronic
bronchitis, and one chronic sinusitis. Three patients had
re£ux esophagitis: of these, two were smokers.One pa-
tientused an angiotensin II-blocker, andno patientswere
taking ACE-inhibitors of b-blockers. The controls com-
prised 73 non-smoking, subjectively healthy volunteers
(42 women and 31 men, 17^72 years of age, mean 41
years).The capsaicin test was performed on all patients
and healthy controls.iratory symptoms atthe Allergy Centre during1year
n= 51) Men (n= 44) Total (n = 95)
2.47] 1.3 [0.81; 1.69] 1.6 [1.31; 1.98]
; 0.98] 0.5 [0.26; 0.69] 0.6 [0.46; 0.78]
%) 32 (73%) 59 (62%)
) 7 (16%) 11 (12%)
%) 6 (14%) 19 (20%)
%) 30 (68%) 55 (58%)
%) 11 (25%) 24 (25%)
%) 6 (14%) 16 (17%)
) 10 (23%) 16 (17%)
%) 10 (23%) 20 (21%)
) 6 (14%) 12 (13%)
) 3 (7%) 10 (11%)
) 10 (23%) 17 (18%)
%) 14 (32%) 36 (38%)
) 5 (11%) 8 (8%)
FIG. 1. The distributionofthenumberofcoughs aftercapsaicin
inhalation (2.0 mM) in 95 patients with upper and/or lower air-
way symptoms.The distribution is bi-phasic, indicating two po-
pulations.
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The testwas initiatedwith inhalation of1ml of normal sal-
ine for 6min, followed by 4min of rest, as previously de-
scribed (1).The provocation was not administered during
an acute respiratory air infection. For inhalation, a nebuli-
ser was used (Pariboy 36, Paulritzau Pari-werk KG, Starn-
berg-am-See, Germany). The number of coughs was
registered with a tape recorder and counted for 10min
from the start of provocation. Thereafter, the subject
wasprovokedin the samemannerwith increasing concen-
trations of capsaicinF0.4, 2.0 and10mMin a1ml solution.
If a subject responded withX70 coughs during one dose,
no more capsaicin was administered; however, the count-
ing of coughs continued for 10min.The limit of 70 coughs
to abolish the inhalation of capsaicin was set according to
previous experience of what a subject could bear.
Statistics
The coughresponses to eachdose of capsaicinwere com-
pared by paired t-test after a logarithmic transposition.
Therelationbetweenpatient symptom score andnumber
of coughs after capsaicin inhalation test was analysed by
linear regression. In comparing patients and healthy con-
trols, a 95% con¢dence interval (CI)was used and the lim-
it for a pathological response to the capsaicin inhalation
test was determined.To investigate possible confounders
for SHR, a multiple logistic regression was ¢tted to the
data. The following explanatory variables were selected
in this model: age, sex, presence of asthma and rhinitis,
sensitivity to cold air, smoking, and interactions of these
variables.To keep this model as parsimonious and plausi-
ble as possible, stepwise selection (forward and back-
ward) procedures were used. The signi¢cance level for
entry and removal of a variablewas set to 5%.
RESULTS
One patient started the provocation with normal saline
but was afraid to continue with capsaicin, and three
individuals were afraid to undergo the provocation with
the highest dose. Therefore, 95 patients were taken
through the entireprotocol. All controls passed the test.
The test itself was harmless and well tolerated, and no
serious side-e¡ects were registered.
Both patients and controls coughed more with in-
creasing doses of capsaicin, and there was a statistically
signi¢cant dose^response relationship for the capsaicin
provocation at each dose with a P-value of at least
o0.001. The e¡ect of capsaicin in the patients by the
2.0mM capsaicin provocation is shown in Fig. 1. The bi-
phasic appearance indicates that this population consists
of two subgroups, one of which seems to bemore sensi-
tive to capsaicin than themajority.There was a direct relationship between the number
of coughs and the symptom score of sensitivity to odours
(correlation coe⁄cient r2=0.34, Po0.0001, capsaicin
2.0mM).Out of 95 patients, 60 (63%) reported any sensi-
tivity to odours. Patients who exhibited pronounced
symptoms, here identi¢ed with a total upper and lower
airway symptom score of at least 4, were diagnosedwith
SHR. In total,15 patients (11women and 4men,mean age
42 years old) ful¢lled this criteria.The e¡ect of the cap-
saicin provocation test was then compared between
three groups: patients with SHR, patients without SHR
and healthy controls (Table 2). Patients with SHR
coughed signi¢cantly more on capsaicin than the other
groups. By studying the mean capsaicin response and
the CIs inTable 2 for the healthy controls and patients,
the cut-o¡ values for SHR could be approximately10, 35
and 55 coughs for 0.4, 2.0 and 10mM capsaicin, respec-
tively (Fig. 2). SHRwas related to gender (females), rhini-
tis and lower airway sensitivity to cold air, butnot to age,
asthma or smoking.
DISCUSSION
Upper and lower airway complaints from contact with
various chemical substances, such as perfumes, cleaning
agents, £ower scents, car exhaust fumes and tobacco
smoke, are common among patients with airway
problems who are referred to the Allergy Centre.
Epidemiological studies are needed to establish the fre-
quency of this condition in the general population (to be
published). In this study, we established three limit values
for the capsaicin inhalation test for patients with pro-
nounced sensitivity to odours and symptoms in the
upper and lower airways. These patients constitute a
clinical population in an allergy centre, thus their symp-
toms variedgreatly. It is necessary to develop amore so-
phisticated questionnaire to identify patients with SHR,
FIG. 2. The mean number of coughs (7SEM) after provoca-
tion with saline and three doses of capsaicin in patients with
SHR (¢lled circles, n= 15), and others patients without SHR
(n= 80) andnon-smokinghealthy subjects (squares, n= 73).The
dotted line represents the upper limit for a normal capsaicin in-
halationtest.
TABLE 2. Results of the capsaicin inhalation test, number of coughs (mean and 95% CI), in three groups: patients with SHR,
other patientswithupper and lower airway symptoms, andhealthycontrols
Capsaicin
Group N Saline 0.4 mM 2.0 mM 10.0 mM
Patientswith SHR 15 5.2[0; 10.5] 32.2 [8.4; 56.0] 70.5 [42.9; 98.2] 83.1 [60.1; 106.2
Other patients 80 0.9 [0.2; 1.6] 10.5 [5.5; 15.4] 21.7 [15.6; 27.8] 41.9 [34.9; 48.8]
Controls 73 0.2 [0; 0.4] 1.3 [0.6; 1.9] 5.6 [3.8; 7.5] 21.2 [17.8; 24.6]
734 RESPIRATORYMEDICINEone with a combined score of symptoms and social re-
strictions related to sensitivity to odours.
A study model designed to illustrate the variety of
symptoms in large patient groups should be simple and
should not require a great deal of time or resources.We
feel that our way of carrying out the capsaicin inhalation
test meets these requirements and the method has
shown good reproducibility (1).We chose to use a com-
mon inhalation apparatus that was loaded with a small
amount of liquid (1ml).This produced a large number of
particles45mM, meaning that a smaller amount of par-
ticles dispersed peripherally (13). The limit values that
were obtained for a positive capsaicin inhalation test de-
pend on this design and cannot be used directly for inha-
lation with another inhaler or with di¡erent amounts of
liquid. In future, itmight be possible to use only one con-
centration of capsaicin. In performing the capsaicin inha-
lation, saline and lowest dose of capsaicin are likely to be
of key importance for training the patient. Discomfort
with the capsaicin inhalation may cause patients to
change theway they inhale.Certain individuals can avoid
coughing to a certain extent, but with a higher concen-
tration the cough re£ex becomes irresistible.Therefore,
even a low, less irritating dose may be of value for the
test.
The degree of sensitivity to capsaicin was positively
related to the symptoms induced by chemicals andodours. Itmust be emphasised that the inhalation test is
non-speci¢c, as other patient groups have also shown in-
creased sensitivity to capsaicin (14^18).However, among
patients with airway problems who were admitted for
allergy exams, we could identify a group of individuals
who claimed to be distinctly sensitive to chemical sub-
stances such as perfumes, £ower scents and tobacco
smoke. After provocation of all patients andhealthy con-
trolswith inhalation of capsaicin, we established limit va-
lues for a positive capsaicin inhalation test for patients
with SHR. The capsaicin inhalation test is not harmful
and can be administered safely to patients with airway
problems.
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